Regulatory Writing Series #1: What Is Regulatory Writing? A Clear Guide for Startups and Research Teams
Regulatory Writing Series #1: What Is Regulatory Writing? A Clear Guide for Startups and Research Teams by Charles Replogle, COO of ScienceDocs 14 March 2025 If your startup or research team is developing a medical product, drug, biologic, or device, regulatory writing is one of the most critical—and often misunderstood—components of your journey toward approval. But […]
Maximizing Direct Costs Under the Threatened NIH 15% Indirect Cap
Maximizing Direct Costs Under the Threatened NIH 15% Indirect Cap by Charles Replogle, COO of ScienceDocs 9 February 2025 The recent announcement capping NIH indirect costs at 15% has left many university researchers scrambling to reassess their budgets, with fear of whether they can continue to find the funds for critical resources that they currently […]